Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice

about

Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice

Item

http://www.wikidata.org/entity/Q39985668

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice

@en

Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice.

@nl

type

Item

label

Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice

@en

Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice.

@nl

prefLabel

Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice

@en

Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice.

@nl

P1476

Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice

@en

P2093

Anshu Marathe

http://www.w3.org/2001/XMLSchema#string

Donald E Mager

http://www.w3.org/2001/XMLSchema#string

Jennifer Visich

http://www.w3.org/2001/XMLSchema#string

Suhasini Iyer

http://www.w3.org/2001/XMLSchema#string

Zhihua Julia Qiu

http://www.w3.org/2001/XMLSchema#string

P2860

Recent advances of novel targeted therapy in non-small cell lung cancer

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

Characterization of a new member of the TNF family expressed on antigen presenting cells

TALL-1 is a novel member of the TNF family that is down-regulated by mitogens

BAFFled B cells survive and thrive: roles of BAFF in B-cell development

Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production

A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells.

Comparison of four basic models of indirect pharmacodynamic responses

P304

3180-3187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-012-0813-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22806404

http://www.w3.org/2001/XMLSchema#string

P932

3632054

http://www.w3.org/2001/XMLSchema#string